Downstream Processing in Biopharmaceuticals - Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness - GBI Research Reports

Downstream Processing in Biopharmaceuticals - Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness

Downstream Processing in Biopharmaceuticals - Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness - GBI Research Reports
Downstream Processing in Biopharmaceuticals - Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness
Published Nov 01, 2012
59 pages — Published Nov 01, 2012
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Research, the leading business intelligence provider, has released its latest research, Downstream Processing in Biopharmaceuticals - Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness, which provides key data, information and analysis of the Contract Manufacturing Organization (CMO) industry, and the downstream processing and reagent market. The report provides comprehensive insight into the size of the CMO market, the downstream processing and reagent market and includes forecasts, key reasons for outsourcing, market characterization, downstream process in biopharmaceuticals, major reagents, reagent suppliers and the reagent market related to downstream processing, profiles of key equipment players, key reagent players and key CMO players, drivers and restraints and deals analysis.

This report is built using data and information sourced from proprietary databases, primary and secondary research and uses in-house analysis from GBI Researchs team of industry experts.

Major CMOs offer both upstream and downstream manufacturing functions equally. In addition to manufacturing in biopharmaceutical production, they also offer clinical trials, logistics, packaging, and even marketing. According to industry experts, almost 60% of the CMO market in dominated by manufacturing functions, out of which more than 50% is dominated by the downstream process. GBI research suggests that the CMO market size for downstream processing is set to grow at a Compound Annual Growth Rate (CAGR) of 15.1%, which is more than the growth in the overall CMO biopharmaceutical market.

Scope

- A detailed overview of the downstream processing, CMO industry and reagent market.
- Annualized market data and forecasts for the downstream processing, CMO industry and reagent market.
- A detailed overview of key reasons behind outsourcing, outsourcing service models and key drivers and restraints of the market.
- A detailed discussion of the downstream processing.
- Company profiles of major equipments suppliers, CMOs and reagent players including the key services offered by them and their financial information.
- Analysis of the Merger and Acquisition (M&A) deals involving key companies

Reasons to buy

- Develop market-entry and market expansion strategies by identifying areas for high growth and opportunities.
- Understand the factors shaping the downstream processing, CMO industry and reagent market.
- Identify the top players in the major equipment suppliers, CMO and reagent market, their financial revenues, geographical presence and key services offered.
- Analyze the key geographies that are lucrative markets for the downstream processing and as well as CMOs.
- Analyze the trends in licensing and M&A deals and explore potential investment opportunities
- Understand upcoming trends that are poised to drive the future growth of the downstream processing

  
Source:
Document ID
GBIHC215MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents54
  List of Tables71
  List of Figures81
Downstream Processing in Biopharmaceuticals - Introduction91
Downstream Processing in Biopharmaceuticals - Market Overview105
  Overview of Biopharmaceuticals101
    Cytokines101
    Enzymes101
    Hormones101
    Clotting Factors101
    Vaccines111
    Monoclonal Antibodies111
    Cell Therapies111
    Antisense Drugs111
    Peptide Therapeutics111
  Overview of Downstream Processing in Biopharmaceuticals121
    A Typical Downstream Processing Operation131
      Initial Clarification131
      Initial Capture131
      Intermediate Purification131
      Final Polishing141
    Major Check Points during Downstream Processing141
      Clear Project Goal141
      Checks for Process Robustness141
      Validated Down-scale141
      Virus Clearance141
      Virus Panel141
      Spiking Studies141
Downstream Processing in Biopharmaceuticals - Role of Downstream Processing in the Biopharmaceutical Industry159
  Major Reagents, Reagent Suppliers and Reagents Market related to Downstream Process181
    Major Reagents181
      Protein Extraction Kit/Reagents181
      Filter Media181
      Protein A Media181
      Balanced Salt Solutions181
      Biological Buffers181
      Polyethylene Glycol181
      Glycyl-glycine181
      5Resin / Agarose191
    Reagent Suppliers192
    Reagent Market211
  Major Equipment Suppliers222
Downstream Processing in Biopharmaceuticals - Downstream Processing Market for CMOs244
  Global CMO Market Overview241
  CMO Biopharmaceuticals Market Characterization242
  CMO Market Size for Downstream Processing262
Downstream Processing in Biopharmaceuticals - Challenges and Unmet Needs in Downstream Bioprocess283
  Challenges281
    Chromatographic Capture281
    Reducing the Purification Steps281
    Titer Increment/Capacity Bottleneck291
    Virus Clearances291
    Scaling Up291
  Unmet Needs291
    Unmet Medical Needs291
    Realistic Achievement of Economies of Scale291
    Technological Development of Disposables at Large Scale301
    Reagent Costs and their Effectiveness301
Downstream Processing in Biopharmaceuticals - Emerging Technologies and their Implications313
  Single Use Technology/Disposable Technology321
    Advantages321
    Disadvantages321
  Multi-column Chromatography321
    Advantages321
    Disadvantages331
  Tangential Flow Filtration331
    Advantages331
    Disadvantages331
Downstream Processing in Biopharmaceuticals - Industry Analysis345
  Key Drivers and Restraints341
    Key Drivers of Downstream Processing Market341
      Changing Focus towards Downstream Processing341
      Multicolumn Chromatography will Dominate the Market341
      Single-use Technologies will be Widely Used341
      Increasing Size of Contract Manufacturing Organizations in Emerging Market341
    Key Restraints of Downstream Processing Market351
      High Cost351
      Low Technical Expertise351
      Reduced Number of Purification Runs351
  Porter s Five Forces Model for Industry Analysis361
    Barriers to Entry361
    Determinants of Buyers Power371
    Determinant of Suppliers Power371
    Threat of Substitute Products371
    Rivalry among Existing Firms371
  Major Events and their Impact Analysis381
Downstream Processing in Biopharmaceuticals - Competitive Landscape3917
  Market Dynamics of Downstream Processing and Impact391
    Market Structure391
  Key Equipment Players401
    Pall Corporation401
      Business Overview401
      M&A Deals411
    Millipore421
      Business Overview421
      M&A Deals431
    Sartorius Stedim Biotech S.A.441
      Business Overview441
      M&A Deals451
  Key Reagent Players461
    Life Technologies461
      Business Overview461
      M&A Deals471
    Sigma Aldrich481
      Business Overview481
      M&A Deals491
  Key CMO Players501
    Lonza501
      Business Overview501
      M&A Deals511
    Boehringer Ingelheim521
      Business Overview521
      M&A Deals531
    Diosynth Biotechnology541
      Business Overview541
      M&A Deals551
Downstream Processing in Biopharmaceuticals - Appendix564
  Market Definitions561
  Abbreviations561
  Bibliography571
  Research Methodology582
    Coverage581
    Secondary Research581
    Primary Research591
    Expert Panel Validation591
  Contact Us591
  Disclaimer591

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Downstream Processing in Biopharmaceuticals - Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness" Nov 01, 2012. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Downstream-Processing-in-Biopharmaceuticals-Adoption-of-Disposable-Technology-at-Improved-Economies-of-Scale-to-Optimize-Production-Efficiency-and-Cost-effectiveness-2115-514>
  
APA:
GBI Research Reports. (2012). Downstream Processing in Biopharmaceuticals - Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness Nov 01, 2012. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Downstream-Processing-in-Biopharmaceuticals-Adoption-of-Disposable-Technology-at-Improved-Economies-of-Scale-to-Optimize-Production-Efficiency-and-Cost-effectiveness-2115-514>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.